Biocon Limited (NSE:BIOCON)
India
· Delayed Price · Currency is INR 354.40
+3.90 (1.11%)
Jun 27, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Biosimilars | 88.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biosimilars Growth | 58.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research | 34.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research Growth | 9.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Generics | 25.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Generics Growth | 1.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Novels | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Novels Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biologics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biologics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Branded Formulations | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Branded Formulations Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
United States | 64.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 55.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
European Union (Including Ireland) | 35.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World | 31.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World Growth | -24.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India | 16.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India Growth | -3.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ireland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ireland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|